Skip to main content

Table 1 Summary of trial data used for regression modelling

From: Asymptomatic recrudescence after artemether–lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis

Quantity

Value

Total number of trials

70

Reporting days

2 trials reported on day 14, 56 trials on day 28, 22 trials on day 42, one trial on day 45, one on day 56

MAP prevalence estimates (mean and range)

25.9% (0.2%, 86.5%)

Trials treating young children only (< 72 months)

26

Total number of patients treated

8616

Patients treated in each trial (mean and range)

123 (23, 665)

Total number of patients for whom treatment failed

14 ETFs, 380 recrudescences (of which 219 were asymptomatic and 161 (42.4%) were symptomatic)

  1. These data come from 60 published studies, splitting multi-centred studies by site (see full data in Additional file 2). This Table does not include data from 5 multi-country studies for which data could not be stratified by site (these data are included in the findings reported in Results section)